NEW YORK (GenomeWeb News) – WaferGen Biosystems and NuGen Technologies today announced a collaboration to co-develop and co-market workflows for gene expression profiling and target enrichment.
Under the terms of the deal, the companies will jointly conduct development projects for validated workflows with NuGen's sample preparation and isothermal linear amplification products and WaferGen's SmartChip Real-Time PCR system. The focus of the projects will be on solutions for sample preparation, pre-amplification, and nucleic acid detection for gene expression and target enrichment from different sample types.
Financial and other terms of the deal were not disclosed.
The deal, the two firms said, will enable researchers to more easily perform high-throughput, high-density real-time PCR with small, degraded, and hard-to-replace specimens, including formalin-fixed, paraffin-embedded tissue.
"By combining the expertise of both companies, we can offer a simple and straightforward workflow solution for single cell analysis, archival tissues and next-generation sequencing addressing the needs of customers with precious nucleic acid samples who wish to perform high-throughput, high-density real-time PCR," Alnoor Shivji, chairman and CEO of WaferGen, said in a statement. "This will expand the market potential of our SmartChip System by offering ready-to-go applications for biomarker discovery, validation and screening."